128 related articles for article (PubMed ID: 10102916)
41. Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors.
Bernini G; Moretti A; Fontana V; Orlandini C; Miccoli P; Berti P; Basolo F; Faviana P; Bardini M; Salvetti A
Eur J Endocrinol; 2004 Aug; 151(2):215-22. PubMed ID: 15296477
[TBL] [Abstract][Full Text] [Related]
42. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies.
Portel-Gomes GM; Grimelius L; Johansson H; Wilander E; Stridsberg M
Am J Surg Pathol; 2001 Oct; 25(10):1261-7. PubMed ID: 11688460
[TBL] [Abstract][Full Text] [Related]
43. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
[TBL] [Abstract][Full Text] [Related]
44. Measurements of chromogranin B can serve as a complement to chromogranin A.
Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
[TBL] [Abstract][Full Text] [Related]
45. Human pituitary tumors secrete chromogranin-A.
Deftos LJ; O'Connor DT; Wilson CB; Fitzgerald PA
J Clin Endocrinol Metab; 1989 May; 68(5):869-72. PubMed ID: 2715290
[TBL] [Abstract][Full Text] [Related]
46. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
[TBL] [Abstract][Full Text] [Related]
47. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
[TBL] [Abstract][Full Text] [Related]
48. Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations.
Pawlikowski M; Gruszka A; Radek M; Kunert-Radek J
Folia Histochem Cytobiol; 2004; 42(4):245-7. PubMed ID: 15704652
[TBL] [Abstract][Full Text] [Related]
49. Selective processing of chromogranin A in the different islet cells in human pancreas.
Portela-Gomes GM; Stridsberg M
J Histochem Cytochem; 2001 Apr; 49(4):483-90. PubMed ID: 11259451
[TBL] [Abstract][Full Text] [Related]
50. A cloned chromogranin A (CgA) cDNA detects a 2.3Kb mRNA in diverse neuroendocrine tissues.
Deftos LJ; Murray SS; Burton DW; Parmer RJ; O'Connor DT; Delegeane AM; Mellon PL
Biochem Biophys Res Commun; 1986 May; 137(1):418-23. PubMed ID: 3718511
[TBL] [Abstract][Full Text] [Related]
51. [Usefulness of chromogranin A determination in the diagnosis of neuroendocrine neoplasia].
Militello C; Cannizzaro R; Pradella P; Volpin E; Spirch S; Buonadonna A; De Appollonia L; Rossi C; Sigon R; Cipresso S; Terranova O
Chir Ital; 1999; 51(1):45-51. PubMed ID: 10514916
[TBL] [Abstract][Full Text] [Related]
52. Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors.
Gadroy P; Stridsberg M; Capon C; Michalski JC; Strub JM; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
J Biol Chem; 1998 Dec; 273(51):34087-97. PubMed ID: 9852066
[TBL] [Abstract][Full Text] [Related]
53. Development of an ELISA for the detection of serum chromogranin A (CgA) in prostate and non-neuroendocrine carcinomas.
Tsao KC; Wu JT
Clin Chim Acta; 2001 Nov; 313(1-2):21-9. PubMed ID: 11694235
[TBL] [Abstract][Full Text] [Related]
54. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance of elevated serum chromogranin A levels.
Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
[TBL] [Abstract][Full Text] [Related]
56. Development of a microplate assay for serum chromogranin A (CgA): establishment of normal reference values and detection of elevated CgA in malignant diseases.
Wu TL; Chang CP; Tsao KC; Sun CF; Wu JT
J Clin Lab Anal; 1999; 13(6):312-9. PubMed ID: 10633301
[TBL] [Abstract][Full Text] [Related]
57. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
[TBL] [Abstract][Full Text] [Related]
58. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
[TBL] [Abstract][Full Text] [Related]
59. Chromogranin A assay in clinical practice.
d'Herbomez M; Do Cao C; Vezzosi D; Borzon-Chasot F; Baudin E;
Ann Endocrinol (Paris); 2010 Sep; 71(4):274-80. PubMed ID: 20538257
[TBL] [Abstract][Full Text] [Related]
60. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
